RETEVMO 40 mg/1 (Selpercatinib CAPSULE) 40 mg/1

RETEVMO 40 mg capsules are a prescription medication used to treat certain types of cancer. This oral medication is designed to target specific genetic mutations, offering a targeted approach to cancer therapy.

Strength

40 mg/1

Pack Size

60 CAPSULE in 1 BOTTLE (0002-3977-60)

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RETEVMO 40 mg capsules are primarily used in the treatment of advanced or metastatic cancers that harbor specific genetic alterations. These capsules are often prescribed for patients with RET fusion-positive cancers, providing a tailored treatment option for those with these genetic markers. RETEVMO is used to address the underlying genetic drivers of cancer, aiming to slow or halt disease progression.

Side Effects

Common effects of RETEVMO 40 mg capsules may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some patients may also experience fatigue, muscle pain, or changes in taste. These effects can vary in severity and duration, and it's important to discuss any persistent or concerning symptoms with a healthcare provider.

Precautions & Warnings

RETEVMO 40 mg capsules should be handled with care, following the prescribed dosage and administration instructions. It is essential to inform your healthcare provider about any pre-existing medical conditions or allergies before starting this medication. Pregnant women or those planning to become pregnant should consult their healthcare provider due to potential risks.

Avoid Interactions

RETEVMO 40 mg capsules may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to discuss all current medications, including over-the-counter drugs and supplements, with your healthcare provider to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider, as it may affect the efficacy or safety of RETEVMO.

Frequently Asked Questions

RETEVMO 40 mg capsules are used to treat certain types of cancer with specific genetic alterations, particularly RET fusion-positive cancers.

RETEVMO 40 mg capsules are taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include diarrhea, nausea, vomiting, fatigue, muscle pain, and changes in taste.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

Pregnant women or those planning to become pregnant should consult their healthcare provider due to potential risks.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.